ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,724.30
-0.33%
S&P ASX All Technology
3,092.70
-1.13%
Brent Oil
82.275
0.00%
US Dollar vs AUD
1.51378
0.08%
Bitcoin
66,291.26
0.43%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Endonovo Therapeutics Inc (PK) (ENDV)

  7. Endonovo Therapeutics Inc (PK) (ENDV) News

ENDV

Endonovo Therapeutics (PK) (ENDV)

Endonovo Therapeutics Inc (PK)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:ENDV
DateTimeSourceHeadlineSymbolCompany
03/02/202409:23Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]USOTC:ENDVEndonovo Therapeutics Inc (PK)
04/01/202409:30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ENDVEndonovo Therapeutics Inc (PK)
30/12/202307:20Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]USOTC:ENDVEndonovo Therapeutics Inc (PK)
05/12/202301:08Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ENDVEndonovo Therapeutics Inc (PK)
16/11/202304:21Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:ENDVEndonovo Therapeutics Inc (PK)
12/10/202321:03Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ENDVEndonovo Therapeutics Inc (PK)
25/08/202321:04Edgar (US Regulatory)Form 1-A/A - Offering Statement [Regulation A]: [Amend]USOTC:ENDVEndonovo Therapeutics Inc (PK)
22/08/202307:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:ENDVEndonovo Therapeutics Inc (PK)
15/06/202304:27Edgar (US Regulatory)Amended Registration a Offering Under the Securities Act of 1933 (1-a/a)USOTC:ENDVEndonovo Therapeutics Inc (PK)
16/05/202320:02Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ENDVEndonovo Therapeutics Inc (PK)
18/04/202306:39Edgar (US Regulatory)Annual Report (10-k)USOTC:ENDVEndonovo Therapeutics Inc (PK)
01/04/202306:55Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:ENDVEndonovo Therapeutics Inc (PK)
29/03/202322:01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ENDVEndonovo Therapeutics Inc (PK)
15/11/202201:27Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ENDVEndonovo Therapeutics Inc (PK)
28/09/202203:31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ENDVEndonovo Therapeutics Inc (PK)
22/08/202223:14Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ENDVEndonovo Therapeutics Inc (PK)
15/08/202223:46Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ENDVEndonovo Therapeutics Inc (PK)
16/05/202223:01Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ENDVEndonovo Therapeutics Inc (PK)
11/05/202208:36Edgar (US Regulatory)Amended Registration a Offering Under the Securities Act of 1933 (1-a/a)USOTC:ENDVEndonovo Therapeutics Inc (PK)
01/04/202207:18Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:ENDVEndonovo Therapeutics Inc (PK)
20/11/202101:02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ENDVEndonovo Therapeutics Inc (PK)
16/11/202102:12Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ENDVEndonovo Therapeutics Inc (PK)
24/08/202105:06Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ENDVEndonovo Therapeutics Inc (PK)
17/08/202100:11Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ENDVEndonovo Therapeutics Inc (PK)
25/05/202106:13Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ENDVEndonovo Therapeutics Inc (PK)
18/05/202106:45Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ENDVEndonovo Therapeutics Inc (PK)
14/04/202107:17Edgar (US Regulatory)Annual Report (10-k)USOTC:ENDVEndonovo Therapeutics Inc (PK)
01/04/202108:01Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:ENDVEndonovo Therapeutics Inc (PK)
20/11/202008:57Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ENDVEndonovo Therapeutics Inc (PK)
20/08/202004:44Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ENDVEndonovo Therapeutics Inc (PK)
 Showing the most relevant articles for your search:USOTC:ENDV

Your Recent History

LSE
FWRA
Ivz Wld Acc
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved